arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Korro Bio, Inc.

KRRO Health Care Biotechnology: Pharmaceutical Preparations
$10.72
▼ -4.1% Today
as of Jun 7, 07:19 ET
Last 30 days -16.25% Apr 28 → Jun 05
$8.78 $10.12 $11.45 $12.79 $14.13 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$11.09
High
$11.28
Low
$10.46
Volume
$187,070
Avg Vol
$270,012
Mkt Cap
$193M
P/E (TTM)
Beta
52w High
$55.89
52w Low
$5.20
Div Yield
Shares Out
$14M

Overview

52-week range
$5.20
$56
11% of range
Avg surprise (last 2)
-0.7%
Avg reaction (last 2)
-4.6%
0% positive
Latest IV / EM
391%
EM ±54.1% · $10 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-65.08$-49.21$-33.34$-17.47$-1.60 Actual $-63.83Actual $-65.08Actual $-2.44Actual $-2.43Actual $-2.26Actual $-2.49Est $-2.60Actual $-2.74Actual $-1.92Actual $-1.69Est $-1.60 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-26M$-19M$-12M$-4M$3M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.69 $-1.60 -5.6% +32.1% -3.4% earnings
Tue Sep 30, 2025Sep 2025 $-1.92 financials
Mon Jun 30, 2025Jun 2025 $-2.74 financials
Wed May 7, 2025Mar/2025 $-2.49 $-2.60 +4.2% -5.8% earnings
Mon Sep 30, 2024Sep 2024 $-2.26 financials
Sun Jun 30, 2024Jun 2024 $-2.43 financials
Sun Mar 31, 2024Mar 2024 $-2.44 financials
Sat Sep 30, 2023Sep 2023 $-65.08 financials
Fri Jun 30, 2023Jun 2023 $-63.83 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$1M$1M$3M$0$0
Cost of revenue
Gross profit
Operating income$-20M$-19M$-27M$-25M$-23M$-24M
Net income$-20M$-18M$-26M$-23M$-21M$-22M
EPS (diluted)$-1.69$-1.92$-2.74$-2.49$-2.26$-2.43

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$62M$22M$24M$34M$64M$56M$63M$91M
Inventory
Total current assets$120M$82M$98M$103M$121M$132M$153M$164M
Total assets$184M$114M$162M$180M$202M$226M$244M$250M
Long-term debt
Total liabilities$64M$62M$63M$65M$63M$66M$64M$52M
Total equity$120M$51M$99M$115M$139M$160M$180M$198M

Implied volatility — last 90 days

385%388%390%393%395% Jun 07 — IV 391% · EM ±54.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.